FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Buckner

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Derek R Johnson; Daniel J Ma; Jan C Buckner; Julie E Hammack
Conditional probability of long-term survival in glioblastoma: a population-based analysis.
Shota Tanaka; Joon H Uhm; Elizabeth S Yan; Jan C Buckner; Fredric B Meyer; Ian F Parney
Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.
Yuanyuan Xiao; Mitchel S Berger; Steve Brem; James E Browning; Jan C Buckner; Susan M Chang; Paul A Decker; Kathleen M Egan; Brooke L Fridley; Helen M Hansen; Robert B Jenkins; Matthew L Kosel; Daniel H Lachance; Melissa H Madden; Lucie S McCoy; L Burt Nabors; Jeffrey J Olson; Brian Patrick O'Neill; Joseph S Patoka; Michael D Prados; Terri Rice; Ivan Smirnov; Reid C Thompson; Tarik Tihan; Joe L Wiemels; John K Wiencke; Margaret R Wrensch
SSBP2 variants are associated with survival in glioblastoma patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Buckner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Derek R Johnson; Daniel J Ma; Jan C Buckner; Julie E Hammack
Conditional probability of long-term survival in glioblastoma: a population-based analysis.
Cancer 2012;118(22):5608-13.
2012: Shota Tanaka; Joon H Uhm; Elizabeth S Yan; Jan C Buckner; Fredric B Meyer; Ian F Parney
Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.
Journal of neuro-oncology 2012;110(2):227-35.
2012: Yuanyuan Xiao; Mitchel S Berger; Steve Brem; James E Browning; Jan C Buckner; Susan M Chang; Paul A Decker; Kathleen M Egan; Brooke L Fridley; Helen M Hansen; Robert B Jenkins; Matthew L Kosel; Daniel H Lachance; Melissa H Madden; Lucie S McCoy; L Burt Nabors; Jeffrey J Olson; Brian Patrick O'Neill; Joseph S Patoka; Michael D Prados; Terri Rice; Ivan Smirnov; Reid C Thompson; Tarik Tihan; Joe L Wiemels; John K Wiencke; Margaret R Wrensch
SSBP2 variants are associated with survival in glioblastoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(11):3154-62.
2012: Keith C Bible; Jan C Buckner; John D Casler; John A Copland; Norman L Eberhardt; Vahab Fatourechi; Robert L Foote; Yolanda I Garces; Clive S Grant; Ian Hay; Nina J Karlin; Jan L Kasperbauer; Ricardo Lloyd; William J Maples; Bryan McIver; Michael E Menefee; Julian R Molina; John C Morris; Honey V Reddi; Melanie L Richards; Ronald L Richardson; Joseph Rubin; Thomas Sebo; Kostandinos Sideras; Robert C Smallridge; Vera J Suman; Geoffrey B Thompson; Sydney A Westphal; Charles Erlichman
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers.
Journal of oncology practice / American Society of Clinical Oncology 2012;8(3 Suppl):e1s-5s.
2011: Jann N. Sarkaria; Joon H Uhm; Wenting Wu; Paul D Brown; Evanthia Galanis; Caterina Giannini; Kurt A Jaeckle; Steven McGraw; Patrick J Peller; Jan C Buckner
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2011;81(2):468-75.
2011: Thomas B Daniels; Sara J Felten; David Schiff; Ross A Abrams; Robert M Arusell; Paul D Brown; Jan C Buckner; Walter J. CURRAN; Wenting Wu; Edward G Shaw
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
International journal of radiation oncology, biology, physics 2011;81(1):218-24.
2011: Kurt A Jaeckle; R B Jenkins; B W Scheithauer; Karla V Ballman; P A Decker; P J Flynn; C Giannini; Jan C Buckner
Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis.
Journal of neuro-oncology 2011;104(1):253-9.
2010: Jann N Sarkaria; Eva Galanis; Wenting Wu; Allan B Dietz; Timothy J Kaufmann; Michael P Gustafson; Paul D Brown; Joon H Uhm; Ravi D Rao; Laurence Doyle; Caterina Giannini; Kurt A Jaeckle; Jan C Buckner
Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(22):5573-80.
2010: Kurt A Jaeckle; Karla V Ballman; Caterina Giannini; Paula J Schomberg; Matthew M Ames; Joel M Reid; Renee M McGovern; Stephanie L Safgren; Evanthia Galanis; Joon H Uhm; Paul D Brown; Julie E Hammack; Robert Arusell; Daniel A Nikcevich; Roscoe F Morton; Donald B Wender; Jan C Buckner
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
Journal of neuro-oncology 2010;99(1):73-80.
2010: Ashley W Jensen; Nadia N Laack; Jan C Buckner; Paula J Schomberg; Cynthia J Wetmore; Paul D. Brown
Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.
International journal of radiation oncology, biology, physics 2010;77(5):1449-56.
2010: Jan C Buckner; Bahram Forouzesh; Charles Erlichman; Manuel Hidalgo; Joseph P Boni; Gary Dukart; Anna Berkenblit; Eric K Rowinsky
Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer.
Investigational new drugs 2010;28(3):334-42.
2010: Wenting Wu; Kathleen R Lamborn; Jan C Buckner; Paul J Novotny; Susan M Chang; Judith R O'Fallon; Kurt A Jaeckle; Michael D Prados
Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma.
Neuro-oncology 2010;12(2):164-72.
2009: Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joseph L Wiemels; Ping Yang; John K Wiencke
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Nature genetics 2009;41(8):905-8.
2009: Evanthia C Galanis; Kurt A Jaeckle; Matthew J Maurer; Joel M Reid; Matthew M Ames; James S Hardwick; John F Reilly; Andrey Loboda; Michael Nebozhyn; Valeria R Fantin; Victoria M Richon; Bernd Scheithauer; Caterina Giannini; Patrick J Flynn; Dennis F Moore; James Zwiebel; Jan C Buckner
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):2052-8.
2009: Marta Santisteban; Jan C Buckner; Joel M Reid; Wenting Wu; Bernd W Scheithauer; Matthew M Ames; Sara J Felten; Daniel A Nikcevich; Martin Wiesenfeld; Kurt A Jaeckle; Evanthia Galanis
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
Journal of neuro-oncology 2009;92(2):165-75.
2009: Gaspar Kitange; Brett L Carlson; Ann C Mladek; Paul A Decker; Mark A Schroeder; Wenting Wu; Patrick T Grogan; Caterina Giannini; Karla V Ballman; Jan C Buckner; C David James; Jann N. Sarkaria
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model.
Journal of neuro-oncology 2009;92(1):23-31.
2008: Alyx B Porter; Dirk M Bernold; Caterina Giannini; Robert L Foote; Michael J Link; Kerry D Olsen; Timothy J Moynihan; Jan C Buckner
Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma.
Journal of neuro-oncology 2008;90(2):201-4.
2008: Lijo Simpson; Shaji K Kumar; Scott H Okuno; Hartzell V Schaff; Luis F Porrata; Jan C Buckner; Timothy J Moynihan
Malignant primary cardiac tumors: review of a single institution experience.
Cancer 2008;112(11):2440-6.
2008: Robert R McWilliams; Ravi D Rao; Jan C Buckner; Michael J Link; Svetomir Markovic; Paul D. Brown
Melanoma-induced brain metastases.
Expert review of anticancer therapy 2008;8(5):743-55.
2008: Paul D. Brown; Paul A Decker; Teresa A Rummans; Matthew M Clark; Marlene H Frost; Karla V Ballman; Robert M Arusell; Jan C Buckner
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life.
American journal of clinical oncology 2008;31(2):163-8.
2007: Dona Locke; Paul A Decker; Jeff A Sloan; Paul D Brown; James F Malec; Matthew M Clark; Teresa A Rummans; Karla V Ballman; Paul L Schaefer; Jan C Buckner
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.
Journal of pain and symptom management 2007;34(6):628-38.
2007: Jan C Buckner; Paul D. Brown; Brian P O'Neill; Frederic B Meyer; Cynthia J Wetmore; Joon H Uhm
Central nervous system tumors.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1271-86.
2007: Jan C Buckner; Judith R O'Fallon; Robert P Dinapoli; Paula J Schomberg; Gist Henry Farr; Paul Schaefer; Caterina Giannini; Bernd W Scheithauer; Karla V Ballman
Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade.
Journal of neuro-oncology 2007;84(3):279-86.
2007: Christopher E Pelloski; Karla V Ballman; Alfred F Furth; LI Zhang; E Lin; Erik P Sulman; Krishna Bhat; J Matthew McDonald; W K Alfred Yung; Howard Colman; Shiao Y Woo; Amy B Heimberger; Dima Suki; Michael D Prados; Susan M Chang; Fred G Barker; Jan C Buckner; C David James; Kenneth Aldape
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2288-94.
2007: Ravi D Rao; Paul D. Brown; Jan C Buckner
Innovation in the management of brain metastases.
Oncology (Williston Park, N.Y.) 2007;21(4):473-81; discussion 482, 484, 489.
2007: James L Leenstra; Fausto J Rodriguez; Christina M Frechette; Caterina Giannini; Scott L Stafford; Bruce E Pollock; Steven E Schild; Bernd W Scheithauer; Robert B Jenkins; Jan C Buckner; Paul D. Brown
Central neurocytoma: management recommendations based on a 35-year experience.
International journal of radiation oncology, biology, physics 2007;67(4):1145-54.
2006: Paul D Brown; Ashley W Jensen; Sara J Felten; Karla V Ballman; Paul L Schaefer; Kurt A Jaeckle; Jane H Cerhan; Jan C Buckner
Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(34):5427-33.
2006: Robert B Jenkins; Hilary Blair; Karla V Ballman; Caterina Giannini; Robert M Arusell; Mark Law; Heather A Flynn; Sandra Passe; Sara Felten; Paul D. Brown; Edward G Shaw; Jan C Buckner
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
Cancer research 2006;66(20):9852-61.
2006: Manuel Hidalgo; Jan C Buckner; Charles Erlichman; Marilyn S Pollack; Joseph P Boni; Gary Dukart; Bonnie Marshall; Lisa Speicher; Laurence Moore; Eric K Rowinsky
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5755-63.
2006: Jan C Buckner; Karla V Ballman; John C Michalak; Gary V Burton; Terrence L Cascino; Paula J Schomberg; Roland B Hawkins; Bernd W Scheithauer; Howard M Sandler; Randolph S Marks; Judith R O'Fallon
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3871-9.
2006: Sunil Krishnan; Paul D. Brown; Karla V Ballman; John B Fiveash; Joon H Uhm; Caterina Giannini; Kurt A Jaeckle; Francois J Geoffroy; L Burt Nabors; Jan C Buckner
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
International journal of radiation oncology, biology, physics 2006;65(4):1192-9.
2006: Nicole E Marshall; Karla V Ballman; John C Michalak; Paula J Schomberg; Gary V Burton; Howard M Sandler; Terrence L Cascino; Kurt A Jaeckle; Jan C Buckner
Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.
Journal of neuro-oncology 2006;77(3):315-20.
2006: Evanthia C Galanis; Jan C Buckner; Matthew J Maurer; Rene Sykora; René Castillo; Karla V Ballman; Bradley J Erickson
Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.
Neuro-oncology 2006;8(2):156-65.
2006: Kurt A Jaeckle; Karla V Ballman; Ravi D Rao; Robert B Jenkins; Jan C Buckner
Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(8):1246-52.
2006: Paul D. Brown; Karla V Ballman; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Bradley Boeve; Lalit Gupta; David F Tang-Wai; Robert M Arusell; Matthew M Clark; Jan C Buckner
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.
Journal of neuro-oncology 2006;76(3):283-91.
2005: Michelle R Mahoney; Daniel J Sargent; Michael J O'Connell; Richard M Goldberg; Paul Schaefer; Jan C Buckner
Dealing with a deluge of data: an assessment of adverse event data on North Central Cancer Treatment Group trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9275-81.
2005: Nadia N Laack; Paul D. Brown; Robert J Ivnik; Alfred F Furth; Karla V Ballman; Julie E Hammack; Robert M Arusell; Edward G Shaw; Jan C Buckner
Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study.
International journal of radiation oncology, biology, physics 2005;63(4):1175-83.
2005: Robert R McWilliams; Ravi D Rao; Paul D. Brown; Michael J Link; Jan C Buckner
Treatment options for brain metastases from melanoma.
Expert review of anticancer therapy 2005;5(5):809-20.
2005: Susan M Chang; Sharon L Reynolds; Nicholas Butowski; Kathleen R Lamborn; Jan C Buckner; Richard S. Kaplan; Darell D Bigner
GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.
Neuro-oncology 2005;7(4):425-34.
2005: Evanthia C Galanis; Jan C Buckner; Matthew J Maurer; Joel M Reid; Mary J Kuffel; Matthew M Ames; Bernd W Scheithauer; Julie E Hammack; George Pipoly; Steven A Kuross
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
Investigational new drugs 2005;23(5):495-503.
2005: Paul D. Brown; Matthew J Maurer; Teresa A Rummans; Bruce E Pollock; Karla V Ballman; Jeff A Sloan; Bradley Boeve; Robert M Arusell; Matthew M Clark; Jan C Buckner
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival.
Neurosurgery 2005;57(3):495-504; discussion 495-504.
2005: Evanthia C Galanis; Jan C Buckner; Matthew J Maurer; Jeffrey I Kreisberg; Karla V Ballman; Joseph P Boni; Josep M Peralba; Robert B Jenkins; Shaker R Dakhil; Roscoe F Morton; Kurt A Jaeckle; Bernd W Scheithauer; Janet Dancey; Manuel Hidalgo; Daniel J Walsh
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5294-304.
2005: Ravi D Rao; Sunil Krishnan; Tom R Fitch; Paula J Schomberg; Robert P Dinapoli; Kathleen Nordstrom; Bernd W Scheithauer; Judith R O'Fallon; Matthew J Maurer; Jan C Buckner
Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
International journal of radiation oncology, biology, physics 2005;61(2):380-6.
2004: Ravi D Rao; Jan C Buckner; Jann N. Sarkaria
Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents.
Current cancer drug targets 2004;4(8):621-35.
2004: Kenneth Aldape; Karla V Ballman; Alfred F Furth; Jan C Buckner; Caterina Giannini; Peter C Burger; Bernd W Scheithauer; Robert B Jenkins; C David James
Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
Journal of neuropathology and experimental neurology 2004;63(7):700-7.
2004: Sunil Krishnan; Paul D. Brown; Bernd W Scheithauer; Michael J Ebersold; Julie E Hammack; Jan C Buckner
Choroid plexus papillomas: a single institutional experience.
Journal of neuro-oncology 2004;68(1):49-55.
2004: Paul D. Brown; Jan C Buckner; Judith R O'Fallon; Nancy L Iturria; Brian Patrick O'Neill; Cerise A Brown; Bernd W Scheithauer; Robert P Dinapoli; Robert M Arusell; Walter Curran; Ross Abrams; Edward G Shaw
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma.
International journal of radiation oncology, biology, physics 2004;59(1):117-25.
2004: Paul D. Brown; Jan C Buckner; Judith R O'Fallon; Nancy L Iturria; Cerise A Brown; Brian Patrick O'Neill; Bernd W Scheithauer; Robert P Dinapoli; Robert M Arusell; Ross A Abrams; Walter Curran; Edward G Shaw
Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial.
International journal of radiation oncology, biology, physics 2004;58(4):1153-60.
2004: Michael D Prados; Wendy Seiferheld; Howard M Sandler; Jan C Buckner; Theodore Phillips; Christopher Schultz; Raul Urtasun; Richard Davis; Philip H Gutin; Terrence L Cascino; Harry S Greenberg; Walter Curran
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
International journal of radiation oncology, biology, physics 2004;58(4):1147-52.
2003: Robert R McWilliams; Paul D. Brown; Jan C Buckner; Michael J Link; Svetomir N Markovic
Treatment of brain metastases from melanoma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(12):1529-36.
2003: Robert R McWilliams; Caterina Giannini; Ian D Hay; John L D Atkinson; Scott L Stafford; Jan C Buckner
Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years.
Cancer 2003;98(2):356-62.
2003: Paul D. Brown; Jan C Buckner; Judith R O'Fallon; Nancy L Iturria; Cerise A Brown; Brian Patrick O'Neill; Bernd W Scheithauer; Robert P Dinapoli; Robert M Arusell; Walter Curran; Ross Abrams; Edward G Shaw
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2519-24.
2003: Paul M Magtibay; Jonathan A Friedman; Ravi D Rao; Jan C Buckner; William A Cliby
Unusual presentation of adult metastatic peritoneal medulloblastoma associated with a ventriculoperitoneal shunt: a case study and review of the literature.
Neuro-oncology 2003;5(3):217-20.
2003: Paul D. Brown; Jan C Buckner; Joon H Uhm; Edward G Shaw
The neurocognitive effects of radiation in adult low-grade glioma patients.
Neuro-oncology 2003;5(3):161-7.
2003: Robert D Ecker; W Richard Marsh; Bruce E Pollock; Ozlem Kurtkaya-Yapicier; Robyn McClelland; Bernd W Scheithauer; Jan C Buckner
Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patients.
Journal of neurosurgery 2003;98(6):1182-7.
2003: Jan C Buckner; Joel M Reid; Keith Wright; Scott H Kaufmann; Charles Erlichman; Matthew Ames; Steve Cha; Judith R O'Fallon; Lawrence J Schaaf; Langdon L Miller
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group.
Cancer 2003;97(9 Suppl):2352-8.
2003: Jan C Buckner; Dean H Gesme; Judith R O'Fallon; Julie E Hammack; Scott L Stafford; Paul D. Brown; Roland Hawkins; Bernd W Scheithauer; Bradley J Erickson; Ralph Levitt; Edward G Shaw; Robert Jenkins
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):251-5.
2002: Svetomir Markovic; Vera J Suman; Robert J Dalton; John E Woods; Robert J Fitzgibbons; Lester E Wold; Jan C Buckner; John W Kugler; James A Mailliard; Kendrith M Rowland; James E Krook; David W Brown; Maria Tria Tirona; Edward T. Creagan
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma.
American journal of clinical oncology 2002;25(6):552-6.
2002: Bradley J Erickson; Norbert G Campeau; Shawn A Schreiner; Jan C Buckner; Brian Patrick O'Neill; Judith R O'Fallon
Triple-dose contrast/magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas.
Journal of neuro-oncology 2002;60(1):25-9.
2002: Hiroko Kuriyama; Kathleen R Lamborn; Judith R O'Fallon; Nancy L Iturria; Thomas Sebo; Paul L Schaefer; Bernd W Scheithauer; Jan C Buckner; Nagato Kuriyama; Robert B Jenkins; Mark Israel
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
Neuro-oncology 2002;4(3):179-86.
2002: Scott Okuno; John H Edmonson; Michelle Mahoney; Jan C Buckner; Stephen Frytak; Evanthia C Galanis
Phase II trial of gemcitabine in advanced sarcomas.
Cancer 2002;94(12):3225-9.
2002: Ravi D Rao; Stephan D Thomé; Judith R O'Fallon; John D Earle; Robert P Dinapoli; Jan C Buckner
Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas.
International journal of radiation oncology, biology, physics 2002;53(2):376-84.
2002: John H Edmonson; Ivy A Petersen; Thomas C Shives; Michelle R Mahoney; Michael G Rock; Michael G Haddock; Franklin H Sim; William J Maples; Mary I O'Connor; Leonard L Gunderson; May L Foo; Douglas J Pritchard; Jan C Buckner; Scott L Stafford
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Cancer 2002;94(3):786-92.
2002: John H Edmonson; Randolph S Marks; Jan C Buckner; Michelle R Mahoney
Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.
Cancer investigation 2002;20(5-6):605-12.
2001: JS Smith; Issei Tachibana; Sandra Passe; Brenda K Huntley; Thomas J Borell; Nancy L Iturria; Judith R O'Fallon; Paul L Schaefer; Bernd W Scheithauer; C David James; Jan C Buckner; Robert B Jenkins
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
Journal of the National Cancer Institute 2001;93(16):1246-56.
2001: Jan C Buckner; Paula J Schomberg; William L McGinnis; Terrence L Cascino; Bernd W Scheithauer; Judith R O'Fallon; Roscoe F Morton; Steven A Kuross; James A Mailliard; Alan K Hatfield; J T Cole; P D Steen; Albert M Bernath
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
Cancer 2001;92(2):420-33.
2001: Jonathan A Friedman; J J Lynch; Jan C Buckner; Bernd W Scheithauer; Corey Raffel
Management of malignant pineal germ cell tumors with residual mature teratoma.
Neurosurgery 2001;48(3):518-22; discussion 522-3.
2000: E Galanis; Jan C Buckner
Chemotherapy of brain tumors.
Current opinion in neurology 2000;13(6):619-25.
2000: S V Rajkumar; Joel M Reid; P J Novotny; Stephanie L Safgren; B W Scheithauer; P S Johnson; S Nair; Roscoe F Morton; A K Hatfield; James E Krook; Matthew M Ames; Jan C Buckner
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma.
Journal of neuro-oncology 2000;49(3):255-61.
2000: Patrick A Burch; Albert M Bernath; Terrence L Cascino; Bernd W Scheithauer; Paul J Novotny; Suresh Nair; Jan C Buckner; DM Pfeifle; John W Kugler; Loren K Tschetter
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.
Investigational new drugs 2000;18(3):275-80.
2000: Evanthia C Galanis; Jan C Buckner; Paul J Novotny; Roscoe F Morton; William L McGinnis; Robert P Dinapoli; Paula J Schomberg; Judith R O'Fallon
Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas.
Journal of neurosurgery 2000;93(2):201-7.
2000: Patrick A Burch; J K Breen; Jan C Buckner; Dennis A Gastineau; J A Kaur; Reiner Laus; Douglas J Padley; Madhusudan Peshwa; Henry C Pitot; Ronald L Richardson; B J Smits; P Sopapan; G Strang; Frank H Valone; S Vuk-Pavlović
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2175-82.
1999: Michael D Prados; C Scott; H Sandler; Jan C Buckner; T Phillips; Christopher Schultz; Raul Urtasun; Richard Davis; Philip H Gutin; Terrence L Cascino; Harry S Greenberg; Walter Curran
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
International journal of radiation oncology, biology, physics 1999;45(5):1109-15.
1999: C David James; Evanthia C Galanis; Linda M Frederick; David W Kimmel; Julie M Cunningham; P J Atherton-Skaff; Judith R O'Fallon; Robert B Jenkins; Jan C Buckner; Stephen B Hunter; Jeffrey J Olson; Bernd W Scheithauer
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.
International journal of oncology 1999;15(3):547-53.
1999: Arie Perry; Robert B Jenkins; Judith R O'Fallon; Paul L Schaefer; David W Kimmel; Michelle R Mahoney; Bernd W Scheithauer; S M Smith; E M Hill; T J Sebo; Ralph Levitt; James E Krook; Loren K Tschetter; Roscoe F Morton; Jan C Buckner
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.
Cancer 1999;86(4):672-83.
1999: Jan C Buckner; Prema P Peethambaram; WA Smithson; R V Groover; Paula J Schomberg; David W Kimmel; Corey Raffel; Judith R O'Fallon; Joseph P Neglia; Edward G Shaw
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):933-40.
1999: Jan C Buckner; Mark G Malkin; E Reed; Terrence L Cascino; Joel M Reid; Matthew M Ames; William P Tong; S Lim; W D Figg
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
Mayo Clinic proceedings. Mayo Clinic 1999;74(2):137-45.
1999: M K Gornet; Jan C Buckner; R S Marks; Bernd W Scheithauer; B J Erickson
Chemotherapy for advanced CNS ependymoma.
Journal of neuro-oncology 1999;45(1):61-7.
1999: SV Rajkumar; Jan C Buckner; Paula J Schomberg; Henry C Pitot; J N Ingle; Terrence L Cascino
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Neurosurgery 1999;44(1):67-73.
1998: SV Rajkumar; Jan C Buckner; Paula J Schomberg; Joel M Reid; P J Bagniewski; Matthew M Ames; Terrence L Cascino; Randolph S Marks
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
International journal of radiation oncology, biology, physics 1998;42(5):969-75.
1998: Evanthia C Galanis; Jan C Buckner; Patrick A Burch; Paul L Schaefer; Robert P Dinapoli; Paul J Novotny; Bernd W Scheithauer; Kendrith M Rowland; Allen M Vukov; James A Mailliard; Roscoe F Morton
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2953-8.
1998: Evanthia C Galanis; Jan C Buckner; Robert P Dinapoli; Bernd W Scheithauer; Robert B Jenkins; C H Wang; Judith R O'Fallon; Gist Henry Farr
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Journal of neurosurgery 1998;89(3):425-30.
1998: Bruce V Taylor; Jan C Buckner; Terrence L Cascino; Judith R O'Fallon; Paul L Schaefer; Robert P Dinapoli; Paula J Schomberg
Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2195-201.
1998: Evanthia C Galanis; Jan C Buckner; Bernd W Scheithauer; David W Kimmel; Paula J Schomberg; David G Piepgras
Management of recurrent meningeal hemangiopericytoma.
Cancer 1998;82(10):1915-20.
1998: EA McElroy; Jan C Buckner; Jean E Lewis
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Neurosurgery 1998;42(5):1023-7; discussion 1027-8.
1998: SV Rajkumar; Jan C Buckner; Paula J Schomberg; Terrence L Cascino; Patrick A Burch; Robert P Dinapoli
Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
International journal of radiation oncology, biology, physics 1998;40(2):297-302.
1998: Jan C Buckner; Patrick A Burch; Terrence L Cascino; Judith R O'Fallon; Bernd W Scheithauer
Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma.
Journal of neuro-oncology 1998;36(1):65-70.
1997: Evanthia C Galanis; Jan C Buckner; Paula J Schomberg; Julie E Hammack; Corey Raffel; Bernd W Scheithauer
Effective chemotherapy for advanced CNS embryonal tumors in adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2939-44.
1996: Terrence L Cascino; Michael H Veeder; Jan C Buckner; Judith R O'Fallon; M Wiesenfeld; Ralph Levitt; Richard M Goldberg; Steven A Kuross; Roscoe F Morton; Bernd W Scheithauer
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.
Journal of neuro-oncology 1996;30(3):243-6.
1996: G F Farnell; Jan C Buckner; Terrence L Cascino; M J O'Connell; Paula J Schomberg; V Suman
Brain metastases from colorectal carcinoma. The long term survivors.
Cancer 1996;78(4):711-6.
1995: J A Storlie; Jan C Buckner; G A Wiseman; Patrick A Burch; L C Hartmann; Ronald L Richardson
Prostate specific antigen levels and clinical response to low dose dexamethasone for hormone-refractory metastatic prostate carcinoma.
Cancer 1995;76(1):96-100.
1995: Jan C Buckner; L D Brown; John W Kugler; Terrence L Cascino; James E Krook; J A Mailliard; Carl G Kardinal; Loren K Tschetter; J R O'Fallon; Bernd W Scheithauer
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
Journal of neurosurgery 1995;82(3):430-5.
1995: Ralph Levitt; Jan C Buckner; Terrence L Cascino; Patrick A Burch; Roscoe F Morton; M W Westberg; Richard M Goldberg; J G Gallagher; Judith R O'Fallon; B W Scheithauer
Phase II study of amonafide in patients with recurrent glioma.
Journal of neuro-oncology 1995;23(1):87-93.
1994: Brian Patrick O'Neill; Jan C Buckner; R J Coffey; Robert P Dinapoli; Edward G Shaw
Brain metastatic lesions.
Mayo Clinic proceedings. Mayo Clinic 1994;69(11):1062-8.
1994: T G Call; Edward T. Creagan; S Frytak; Jan C Buckner; C van Haelst-Pisani; H A Homburger; J A Katzmann
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease.
American journal of clinical oncology 1994;17(4):344-7.
1994: J F Quevedo; Jan C Buckner; J L Schmidt; Robert P Dinapoli; Judith R O'Fallon
Thromboembolism in patients with high-grade glioma.
Mayo Clinic proceedings. Mayo Clinic 1994;69(4):329-32.
1994: V Ganju; J H Edmonson; Jan C Buckner
Phase I study of combined alpha interferon, alpha difluoromethylornithine (DFMO), and doxorubicin in advanced malignancy.
Investigational new drugs 1994;12(1):25-7.
1993: Robert P Dinapoli; L D Brown; R M Arusell; John D Earle; Judith R O'Fallon; Jan C Buckner; B W Scheithauer; James E Krook; Loren K Tschetter; J A Maier
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1316-21.
1992: C M van Haelst-Pisani; Ronald L Richardson; J Su; Jan C Buckner; Richard G Hahn; S Frytak; L K Kvols; Patrick A Burch
A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer.
Cancer 1992;70(9):2310-2.
1992: S R Patel; Jan C Buckner; W A Smithson; Bernd W Scheithauer; R V Groover
Cisplatin-based chemotherapy in primary central nervous system germ cell tumors.
Journal of neuro-oncology 1992;12(1):47-52.
1991: C M van Haelst-Pisani; Jan C Buckner; H M Reiman; Daniel J Schaid; J H Edmonson; Richard G Hahn
Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?
Cancer 1991;68(11):2354-8.
1991: H J Long; M D Hauge; T M Therneau; Jan C Buckner; S Frytak; Richard G Hahn
Phase II evaluation of menogaril in patients with advanced hypernephroma.
Investigational new drugs 1991;9(3):261-2.
1991: D L Ahmann; Daniel J Schaid; James N Ingle; H F Bisel; A J Schutt; Jan C Buckner; H J Long; J Rubin
A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer.
American journal of clinical oncology 1991;14(3):179-83.
1991: Charles L Loprinzi; James N Ingle; Daniel J Schaid; Jan C Buckner; J H Edmonson; C J Allegra
5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study.
American journal of clinical oncology 1991;14(1):30-2.
1991: T E Elliott; Jan C Buckner; Terrence L Cascino; Ralph Levitt; Judith R O'Fallon; B W Scheithauer
Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.
Journal of neuro-oncology 1991;10(1):27-30.
1990: Jan C Buckner; L D Brown; Terrence L Cascino; JB Gerstner; James E Krook; M W Westberg; M Wiesenfeld; Judith R O'Fallon; Bernd W Scheithauer
Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma.
Journal of neuro-oncology 1990;9(3):249-54.
1989: J H Edmonson; H J Long; J A Jeffries; Jan C Buckner; G Colon-Otero; Tom R Fitch
Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.
Journal of the National Cancer Institute 1989;81(19):1510-2.
1989: Jan C Buckner; J H Edmonson; James N Ingle; Daniel J Schaid
Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure.
American journal of clinical oncology 1989;12(5):384-6.
1989: J H Edmonson; Jan C Buckner; H J Long; Charles L Loprinzi; Daniel J Schaid
Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas.
Journal of the National Cancer Institute 1989;81(11):863-6.
1989: Jan C Buckner; James N Ingle; L K Everson; Judith R O'Fallon; S A Cullinan; D L Ahmann; James E Krook; D M Pfeifle
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer.
Breast cancer research and treatment 1989;13(2):135-42.
1988: Edward T. Creagan; Jan C Buckner; Richard G Hahn; R R Richardson; D J Schaid; J S Kovach
An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancer.
Cancer 1988;61(9):1787-91.
1988: H J Long; D M Pfeifle; H S Wieand; James E Krook; J H Edmonson; Jan C Buckner
Phase II evaluation of carboplatin in advanced endometrial carcinoma.
Journal of the National Cancer Institute 1988;80(4):276-8.
1988: Charles L Loprinzi; James N Ingle; Daniel J Schaid; Jan C Buckner; J H Edmonson
Progress report on a phase II trial of 5-fluorouracil plus citrovorum factor in women with metastatic breast cancer.
Advances in experimental medicine and biology 1988;244():255-9.